We are live on ! Find out more
HRMY icon

Harmony Biosciences
HRMY

203 hedge funds and large institutions have $2.27B invested in Harmony Biosciences in 2022 Q3 according to their latest regulatory filings, with 44 funds opening new positions, 106 increasing their positions, 33 reducing their positions, and 23 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,336% more call options, than puts

Call options by funds: $5.72M | Put options by funds: $398K

221% more repeat investments, than reductions

Existing positions increased: 106 | Existing positions reduced: 33

91% more first-time investments, than exits

New positions opened: 44 | Existing positions closed: 23

11% more funds holding

Funds holding: 183 → 203 (+20)

7.47% more ownership

Funds ownership: 80.7% → 88.18% (+7.5%)

0% more funds holding in top 10

Funds holding in top 10: 7 → 7 (0)

1% less capital invested

Capital invested by funds: $2.29B → $2.27B (-$22.3M)

Holders
203
Holders Change
+20
Holders Change %
+10.93%
% of All Funds
3.5%
Holding in Top 10
7
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.12%
New
44
Increased
106
Reduced
33
Closed
23
Calls
$5.72M
Puts
$398K
Net Calls
+$5.32M
Net Calls Change
+$2.01M

Top Buyers

Rank Fund Capital Flow
1
Janus Henderson Group
Janus Henderson Group
United Kingdom
+$78.3M
2
Invesco
Invesco
Georgia
+$44.4M
3
BlackRock
BlackRock
New York
+$40.4M
4
Jacobs Levy Equity Management
Jacobs Levy Equity Management
New Jersey
+$20.5M
5
Norges Bank
Norges Bank
Norway
+$17.6M

Top Sellers

Rank Fund Capital Flow
1
Blackstone Inc
Blackstone Inc
New York
-$51.2M
2
VC
Vivo Capital
California
-$33.8M
3
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$21.7M
4
VP
venBio Partners
California
-$15.8M
5
ACM
Ashford Capital Management
Delaware
-$8.61M
Name Holding Trade Value Shares
Change 		Change in
Stake
BBA
201
Baker Bros. Advisors
New York
– -$6.03M -123,600 Closed
IC
202
Ikarian Capital
Texas
– -$4.2M -86,035 Closed
PCM
203
Penserra Capital Management
California
– -$3.76M -77,192 Closed
HP
204
HealthInvest Partners
Sweden
– -$3.71M -76,000 Closed
SCM
205
Suvretta Capital Management
New York
– -$2.86M -58,734 Closed
ACM
206
Altium Capital Management
New York
– -$2.44M -50,000 Closed
AR
207
Advisory Research
Illinois
– -$2.12M -43,430 Closed
EGI
208
EAM Global Investors
California
– -$1.51M -31,072 Closed
EI
209
EAM Investors
California
– -$1.04M -21,276 Closed
CIC
210
Cornercap Investment Counsel
Georgia
– -$981K -20,118 Closed
SG Americas Securities
211
SG Americas Securities
New York
– -$860K -17,626 Closed
RBFC
212
Roman Butler Fullerton & Co
Missouri
– -$885K -16,494 Closed
BFM
213
Boothbay Fund Management
New York
– -$620K -12,711 Closed
GI
214
GAMCO Investors
Connecticut
– -$478K -9,800 Closed
MSRPS
215
Maryland State Retirement & Pension System
Maryland
– -$450K -9,224 Closed
DTL
216
Dynamic Technology Lab
Singapore
– -$371K -7,610 Closed
RJA
217
Raymond James & Associates
Florida
– -$338K -6,932 Closed
VF
218
Virtu Financial
New York
– -$205K -4,207 Closed
Lazard Asset Management
219
Lazard Asset Management
New York
– -$76K -1,566 Closed
CAPTRUST Financial Advisors
220
CAPTRUST Financial Advisors
North Carolina
– -$21K -432 Closed
Rockefeller Capital Management
221
Rockefeller Capital Management
New York
– -$3.07K -63 -95%
DI
222
Disciplined Investments
Oklahoma
– +$49 +1 +20%
JWA
223
JFS Wealth Advisors
Pennsylvania
– +$49 +1 +13%
SIC
224
SJS Investment Consulting
Ohio
– +$195 +4 New
5 6 7 8
9

HRMY Hedge Fund Activity: Q3 2022 in Review

203 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Harmony Biosciences (HRMY) for Q3 2022, worth a combined $2.27B — down 0.97% from $2.29B a quarter earlier.

Buyers outnumbered sellers: 44 funds opened new HRMY positions and 23 closed out — a net gain of 21 holders — while 106 added to existing stakes and 33 trimmed.

The largest buyer was Janus Henderson Group, adding an estimated $78.3M. The largest seller was Blackstone Inc, exiting entirely with an estimated $51.2M sold.

  • 203 institutional investors held Harmony Biosciences (HRMY) as of Q3 2022, up from 183 in Q2 2022.
  • Funds reported $2.27B of Harmony Biosciences stock for Q3 2022, down 0.97% quarter-over-quarter.
  • 44 funds opened new Harmony Biosciences positions in Q3 2022 and 23 closed out, a net change of +21 holders.
  • The largest Harmony Biosciences buyer in Q3 2022 was Janus Henderson Group, an estimated $78.3M added.
  • The largest Harmony Biosciences seller in Q3 2022 was Blackstone Inc, an estimated $51.2M sold.

Based on aggregated 13F filings for Q3 2022.